首页>
外国专利>
EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases
EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases
展开▼
机译:EGLN2变体及其在预防或治疗血栓栓塞性疾病和冠心病中的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention refers to human EGLN2 variants having at position 58 of the amino acid sequence a serine or a leucine and their use in the prevention or treatment of thromboembolic or coronary heart diseases, in particular stroke, prolonged reversible ischemic neurological deficit (PRIND), transitoric ischemic attack (TIA), myocardial infarction and/or early myocardial infarction.
展开▼